Reverberi Gian Piero 4
4 · Vanda Pharmaceuticals Inc. · Filed Mar 4, 2019
Insider Transaction Report
Form 4
Reverberi Gian Piero
SVP, General Manager Europe
Transactions
- Sale
Common Stock
2019-03-04$19.92/sh−443$8,823→ 167,989 total - Sale
Common Stock
2019-03-01$20.16/sh−438$8,832→ 168,432 total
Footnotes (1)
- [F1]Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.